Text Size
84 studies found for:    Fabry Disease

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal (Agalsidase Alfa);   Drug: Replagal
22 Recruiting Home Therapy With Replagal in Fabry Disease
Condition: Fabry's Disease
Intervention:
23 Completed Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains
Conditions: Pain;   Fabry's Disease
Intervention: Genetic: Blood sampling for biological and genetic analysis
24 Completed Analysis of the Nervous System in Patients With Fabry's Disease
Condition: Fabry's Disease
Intervention:
25 Completed Vasodilation in Patients With Fabry's Disease
Conditions: Cerebrovascular Accident;   Fabry Disease;   Healthy
Intervention:
26 Not yet recruiting Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers
Conditions: Fabry Disease, Cardiac Variant;   Right Ventricular Hypertrophy
Intervention:
27 Active, not recruiting Viennese Prevalence Study of Anderson-Fabry Disease
Conditions: Fabry Disease;   Left Ventricular Hypertrophy
Intervention:
28 Completed An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: Replagal agalsidase alfa;   Drug: Replagal
29 Completed Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy
Condition: Focus of Study: Prevalence of Fabry Disease in CKD Population
Intervention:
30 Active, not recruiting Safety Study of Replagal® Therapy in Children With Fabry Disease
Condition: Fabry Disease
Intervention: Biological: Replagal (agalsidase alfa)
31 Completed A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Agalsidase beta (Fabrazyme)
32 Completed Replagal Enzyme Replacement Therapy for Children With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: agalsidase alfa
33 Active, not recruiting Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
Condition: Fabry Disease
Intervention: Drug: AT1001
34 Active, not recruiting Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease
Condition: Fabry Disease
Interventions: Drug: migalastat hydrochloride;   Biological: agalsidase
35 Recruiting Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
36 Recruiting Sophisticated Assessment of Disease Burden in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Procedure: MRI
37 Recruiting Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
Conditions: Fabry Disease;   Cerebrovascular Accident
Intervention: Other: No intervention
38 Completed Neuropathic Pain and Fabry Disease
Condition: Fabry Disease
Intervention:
39 Completed Antiproteinuric Agents and Fabry Disease
Conditions: Fabry Disease;   Proteinuria
Intervention:
40 Completed A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: Fabrazyme (agalsidase beta)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years